Clinical Trial Update: A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient [Phase 3]

View source ↗

Summary

Phase 3 trial studying efepoetin alfa for anaemia associated with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaemia Associated with Chronic Kidney Disease
• Chronic Kidney Disease Anaemia

Drugs mentioned

• Efepoetin Alfa (Efepoetin alfa)

Snippet

Sponsor: PT Kalbe Genexine Biologics | Conditions: Anaemia Associated With Chronic Kidney Disease | Phase 3 | Status: COMPLETED